Oxidative stress biomarkers as indicator of chronic inflammatory joint diseases stage;Biomarcadores de estrés oxidativo como indicadores de actividad en la enfermedad articular inflamatoria crónica

Reumatologia Clinica

Volumn 6, Issue 2, 2010, Pages 91-94

  Feijóo, Montserrat ^a   Túnez, Isaac ^a   Ruiz, Adela ^b   Tasset, Inmaculada ^a   Muñoz, Elisa ^b   Collantes, Eduardo ^b  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Ankylosing spondylitis; Chronic inflammatory joint disease; Oxidative damage; Reactive oxygen species; Rheumatoid arthritis

Indexed keywords

BIOLOGICAL MARKER; GLUTATHIONE; MYELOPEROXIDASE;

ANKYLOSING SPONDYLITIS; ARTHRITIS; ARTICLE; OXIDATIVE STRESS; RHEUMATOID ARTHRITIS; SPECTROPHOTOMETRY;

EID: 75849151524     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2008.12.016     Document Type: Article

References (18)

1. Sies H. Oxidative stress: Oxidants and antioxidans. Exp Physiol 82 (1997) 291-295
2. Ignatowicz E., and Rybezynsda M. Some biochemical and pharmacological aspects of free radical-mediated tissue damage. Pol J Pharmacol 46 (1994) 103-114
3. Kalpakcioglu B., and Senel K. The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis. Clin Rheumatol 27 (2008) 141-145
4. Túnez I., Feijóo M., Huerta G., Montilla P., Muñoz E., Ruiz A., et al. The effect of infliximab on oxidative stress in chronic inflammatory joint disease. Curr Med Res Opin 23 (2007) 1259-1267
5. Prevoo M.L.L., Vant's Hof M.A., Kuper H.H., Van Leuwen M.A., Van de Putte M.A., and Van Riel P.L.C.M. Modified disease activity scores that include twenty-eight-joint counts. Arthritis Rheum 38 (1995) 44-48
6. Garret S.L., Jenkinson T.R., Whitelock H.C., Kennedy L.G., Gainsford G., and Calin A. A new approach to defining disease status of ankylosing spondylitis. The bath ankylosing spondylitis disease activity index. Arthritis Rheum 21 (1994) 2286-2291
7. Levine R.L., Garland D., Olivier C.N., Amici A., Climent I., Lenz A.G., et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1186 (1990) 464-478
8. Flohé L., and Gunzler W.A. Assays of glutathione peroxidase. Methods Enzymol 105 (1984) 114-121
9. Aebi H. Catalase in vitro. Methods Enzymol 105 (1984) 121-126
10. Sun Y., Oberley L.W., and Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 34 (1988) 479-500
11. Filippin L.I., Vercelino R., Marroni N.P., and Xavier R.M. Redox signalling and the inflammatory response in rheumatoid arthritis. Clin Exp Immunol 152 (2008) 415-422
12. Karakoc M., Altindag O., Keles H., Soran N., and Selek S. Serum oxidative-antioxidative status in patients with ankylosing spondilitis. Rheumatol Int 27 (2008) 1131-1134
13. Yazici C., Köse K., Calis M., Kuzugüden S., and Kirnap M. Protein oxidation status in patients with ankylosing spondylitis. Rheumatology (Oxford) 43 (2004) 1235-1239
14. Ozgocmen S., Sogut S., Ardicoglu O., Fadillioglu E., Pekkutucu I., and Akyol O. Serum nitric oxide catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis. Rheumatol Int 24 (2004) 80-83
15. Jira W., Spitellet G., and Richter A. Increased levels of lipid peroxidation products in low density lipoproteins of patients suffering from rheumatoid arthritis. Chem Phys Lipids 87 (1997) 81-89
16. Sánchez-Rodríguez M.A., Osorio E.S., Vargas L.A., and Mendoza-Núñez V.M. Propuesta de un constructo para evaluar integralmente el estrés oxidativo. Bioquimia 29 (2004) 81-90
17. González-Gay M.A., González-Juanatey C., and Martín J. Rheumatoid artritis: A disease associated with accelerated atherogenesis. Semin Arthritis Rheum 35 (2005) 8-17
18. González-Juanatey C., Llorca J., Amigo-Díaz E., Dierssen T., Martín J., and González-Gay M.A. High prevalence of subclinical atherosclerosis in psoriatic artritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factor. Arthritis Rheum 57 (2007) 1074-1080